financetom
Business
financetom
/
Business
/
NSE signs data licensing pact with CME Group for WTI crude oil, natural gas derivatives contracts
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
NSE signs data licensing pact with CME Group for WTI crude oil, natural gas derivatives contracts
Feb 15, 2023 1:33 PM

Leading stock exchange NSE on Wednesday said it has entered into a data licensing agreement with derivatives marketplace CME Group for WTI crude oil and natural gas contracts.

Share Market Live

NSE

The pact will allow National Stock Exchange (NSE) to list, trade and settle rupee-denominated Nymex WTI crude oil and natural gas derivatives contracts for Indian market participants, the bourse said in a statement.

The addition of the contracts will expand the NSE product offering and its overall commodity segment. NSE has applied to the Securities and Exchange Board of India (SEBI) seeking approval to launch the additional futures contracts.

Also Read: LinkedIn layoffs: Microsoft owned employment networking platform begins job cuts

"On receiving approval from Sebi, NSE would make available trading in futures of these two global benchmarks, which will be settled in INR, on the NSE platform.

"The Nymex WTI Crude Oil and Natural Gas (Henry Hub) contracts are amongst the world's most traded commodity derivatives contracts generating interest from across the globe," Sriram Krishnan, Chief Business Development Officer, NSE said.

This would help the exchange broaden its energy basket and these contracts will be beneficial for the Indian market participants to meet their price risk management activities as well as trading objectives, he added.

Also Read: SaaS companies to command 8% of the global market in 5 years: Bain & Co Report

First Published:Feb 15, 2023 10:33 PM IST

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Vertical Aerospace Shares Fall After $60 Million Stock Offering Priced
Vertical Aerospace Shares Fall After $60 Million Stock Offering Priced
Jul 9, 2025
09:18 AM EDT, 07/09/2025 (MT Newswires) -- Vertical Aerospace ( EVTWF ) stock was down nearly 32% in recent Wednesday premarket activity after the company said it has priced an underwritten public offering of its ordinary shares at $5 each for gross proceeds of $60 million. Underwriters have a 30-day option to buy up to an additional 1.8 million shares,...
Global banks predicted to get 10% trading revenue boost on tariff turmoil
Global banks predicted to get 10% trading revenue boost on tariff turmoil
Jul 9, 2025
NEW YORK (Reuters) -Global banks including top U.S. lenders are expected to report a 10% gain in markets revenue as traders cashed in on shifting U.S. tariff policies, according to estimates from analysis firm Crisil Coalition Greenwich. The projections follow a 15% gain in trading revenue in the first quarter for 12 global banks, the data showed. Bank of America...
Eledon Pharmaceuticals, Sernova Collaborate to Test Tegoprubart in Type 1 Diabetes
Eledon Pharmaceuticals, Sernova Collaborate to Test Tegoprubart in Type 1 Diabetes
Jul 9, 2025
09:20 AM EDT, 07/09/2025 (MT Newswires) -- Eledon Pharmaceuticals ( ELDN ) has agreed to collaborate with Sernova Biotherapeutics to evaluate tegoprubart in patients with type 1 diabetes, Sernova said Wednesday. Under the agreement, Eledon will supply tegoprubart to replace tacrolimus in Cohort C of Sernova's phase 1/2 cell pouch bio-hybrid organ trial in patients with type 1 diabetes, according...
Copyright 2023-2026 - www.financetom.com All Rights Reserved